Pinta Biotherapeutics
Brisbane, US · Founded 2012
Find your way into Pinta Biotherapeutics
Sign up to see every warm intro you have to Pinta Biotherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pinta Biotherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Pinta Biotherapeutics was founded in 2012 by Isaac Ciechanover.
IC
Isaac CiechanoverFounder
JF
John F. McGrathExecutive
GS
Gad SofferExecutive
CH
Christopher HaqqExecutive
Board
EW
Eckard WeberBoard director
CG
Carol GallagherBoard director
BS
Beth SeidenbergBoard director
JM
Joel MarcusBoard director
Reported raises · per SEC filings
Form D private placements$6.3M disclosed across 1 round · 2014
▶$6.3MraisedJan 2014 · 10 investors · BiotechnologyRule 506(b)
▶$6.3MraisedJan 2014 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John F. McGrathExecutive Officer
- Gad SofferExecutive Officer
- Eckard WeberDirector
- Carol GallagherDirector
- Beth SeidenbergDirector
- Joel MarcusDirector
- Christopher HaqqExecutive Officer
- Isaac CiechanoverExecutive Officer, Director
- Offering amount
- $6.3M
- Amount sold
- $6.3M
- First sale
- Jan 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Pinta Biotherapeutics?
- Pinta Biotherapeutics was founded by Isaac Ciechanover in 2012.
- How much funding has Pinta Biotherapeutics raised?
- Pinta Biotherapeutics has disclosed $6.3M raised across 1 round.
- Where is Pinta Biotherapeutics headquartered?
- Pinta Biotherapeutics is headquartered in Brisbane, US.